T. Hasegawa: Technological Know-How, Marketing Tactics and Strategic Direction in Flavors and Fragrances

June 2016 | | ID: TD99C2C650BEN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch.com provides strategic assessment of T. Hasegawa's technological know-how, marketing tactics and strategic directions in the global flavor and fragrance market.

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Lymphocyte Subclassification CD4/CD8
      Instrumentation and Reagent Test Kits
      BD

      Beckman Coulter/Danaher
      T Cells Diagnostics

B. CD34

C. Other Cell Markers
D. Instrumentation Review
  1. HEMATOLOGY ANALYZERS
    a. Overview
      Electrical ApertureImpedance Analyzers
      Light Scatter Analyzers
    b. System Review
      Abbott
      Beckman Coulter/Danaher
      Biocode Hycel
      DrewScientific
      Horiba
      Menarini
      Nihon Kohden
      Siemens
      Sysmex
  2. FLOW CYTOMETERS
    a. INTRODUCTION
    b. System Overview
      Becton Dickinson
      Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
  1. INFORMATION TECHNOLOGIES
  2. AUTOMATION AND ROBOTICS
  3. LASERS
  4. ARTIFICIAL INTELLIGENCE
  5. MONOCLONAL ANTIBODIES
  6. MOLECULAR DIAGNOSTICS
  7. MICRODROP TECHNOLOGY
III. France : Forecasts by Test and Market Segment
IV. Germany : Forecasts by Test and Market Segment
V. Italy : Forecasts by Test and Market Segment
VI. Japan : Forecasts by Test and Market Segment
VII. Spain : Forecasts by Test and Market Segment
VIII. U.K. : Forecasts by Test and Market Segment
IX. U.S. : Forecasts by Test and Market Segment

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized

TESTING MARKETS

  1. FOUR MARKETING APPROACHES
  2. PRODUCT COMPLEXITY FACTOR
  3. CUSTOMER PREFERENCE FACTOR
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION FACTOR

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

      Abbott
      Beckman Coulter/Danaher
      Becton Dickinson
      BioRad
      CellaVision
      Dako/Agilent Technologies
      Horiba
      Iris Diagnostics/Danaher
      Nihon Kohden
      OrthoClinical Diagnostics
      Roche
      Siemens
      Sysmex
XIII. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications

List Of Tables

LIST OF TABLES

France, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Germany, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Japan, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Japan, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume Spain, Hospital Laboratories Estimated
Cell Surface Marker Test Volume Spain, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume Spain, Ambulatory Care Center Estimated
Cell Surface Marker Test Volume
U.K., Hospital Laboratories Estimated
Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Hospital Laboratories Estimated
Cell Surface Marker Test Volume U.S., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume U.S., Physician Office Laboratories Estimated
Cell Surface Marker Test Volume